1 Abbreviations: MSH, melanocyte stimulating hormone; ACTH, adrenocorticotropic hormone; RSA, rabbit serum albumin; anti-ACTH, serum from rabbits that have received injections of rabbit serum albumin conjugated with ACTH; anti-MSH, serum from rabbits that have received inj ections of rabbit serum albumin conjugated with a-MSH; eicosapeptide "ACTH," the synthetic N-terminal eicosapeptide of ACTH. tide hormones, including insulin (2), glucagon (3), parathormone (4, 5) , and ACTH (6, 7) . These techniques depend on the availability of antibodies to the hormones. Alpha-MSH is a small polypeptide with a molecular weight of 1,665, and the occurrence of antibodies to this peptide has not been described. We report the generation of antibodies to a-MSH and ACTH in rabbits and suggest that the use of antisera may confer immunologic specificity to the bioassay of a-MSH, and may be useful for direct immunochemical measurement of the hormone.
Methods
Antigenic compounds were synthesized by conjugating rabbit serum albumin (RSA) with either a-MSH or ACTH by means of the carbodiimide reagent [1-ethyl-3 -(3-dimethyl-aminopropyl) carbodiimide], as previously described for bradykinin and other peptides (8) . Five mg of albumin, 5 mg of a-MSH or ACTH, and 100 mg of the carbodiimide reagent were dissolved, in that order, in 0.3 ml water. After 30 minutes a cloudy, gelatinous precipitate formed. The entire mixture was then subjected to dialysis against water for 48 hours. The precipitated material was used for immunization. Antigens for complement fixation were prepared in the same way, except that a different carbodiimide [1- (9) , and specificity was assessed by cross-reactivity of the antisera with other hormone-albumin complexes and by "hapten inhibition" of the complement fixation reaction by free peptides. The dilutions of antisera and the amounts of antigen required for maximal complement fixation were confirmed in three separate experiments, one of which is shown in Figure 1 for each antigen-antibody system. The hapten inhibition studies were performed several times. One complete study is summarized in Table I ; the others confirmed the relative amounts of hormones required for inhibition of complement fixation by the two antisera.
Frog skin bioassay for darkening activity. Four skin samples were obtained from each frog and mounted on rings as previously described (1) . Each compound was tested on a total of four samples from different regions of four frogs. In this way the darkening activity of four substances could be compared in a latin square. The frogs were decapitated and skinned at 7:30 a.m. The skins were trimmed, mounted on rings, placed in beakers, and washed in five changes of Ringer's solution. Peptide was added at 11 :00 a.m. A darkening unit was defined as the degree of darkening produced by 0.04 gg of a lyophilized water extract of beef posterior pituitary powder (1) . Peptides were assayed before use. In each experiment, 10 U of the above posterior pituitary standard was added to a group of skins. Mouse adrenal tumor cells were incubated in culture as described by Buonassisi, Sato, and Cohen (11) . ACTH and serum were added to the culture dishes on the day after the tumor was plated. Steroid secretion was measured by extracting the medium 2 hours later with dichloromethane. The solvent was evaporated, the residue redissolved in ethanol, and the absorbancy measured at 240 m/u. Results of two experiments are recorded in Table II. Materials. Highly purified a-MSH (porcine) free of ACTH was obtained by elution from a carboxymethylcellulose column. ACTH (porcine) free of a-MSH 2 and eicosapeptide "ACTH" 3 were gifts. The rabbit albumin,4 the carbodiimides,5 and the hypophysectomized rats 6 were purchased. The antisera induced by RSA-MSH and RSA-ACTH fixed complement with homologous complexes, as illustrated in Figure 1 . The titers for complete fixation with the homologous antigenic complexes under standard conditions were 1: 25 for anti-MSH and 1: 100 for anti-ACTH. Anti-MSH did not cross-react with RSA-ACTH, but anti-ACTH did fix complement in the presence of RSA-MSH at a titer of 1: 50. Similar specificity characteristics were evident in hapten inhibition assays ( Table I ). The reaction of RSA-MSH with anti-MSH was inhibited by a-MSH but not by ,8-MSH, ACTH, or the eicosapeptide "ACTH."
In contrast, the reaction of RSA-ACTH with anti-ACTH was inhibited by ACTH, eicosapeptide "ACTH," and a-and f-MSH.
Anti-ACTH showed a greater affinity for MSH than did anti-MSH itself. The reaction of 1 ml of anti-ACTH with RSA-ACTH was inhibited 50%o by 2.3 ptg a-MSH, but the reaction of 1 ml anti-MSH with RSA-a-MSH required 10 jug of a-MSH for 50%o inhibition. The smaller amount of hapten required for inhibition of complement fixation reflects the greater ability of anti-ACTH to bind free a-MSH.
Anti-MSH and anti-ACTH decreased the darkening effect of a-MSH as indicated in Figure 2 ferent days. Each experiment has been performed more than 6 times with no substantial variation. Anti-ACTH was a more potent inhibitor of a-MSH darkening than was anti-MSH ( Figure   2 ). Ten ul of the anti-ACTH produced 40%o inhibition and 50 ul produced 90% inhibition of the darkening ability of 20 U of a-MSH (2.5 X 10-5 Mug). When the Ringer's solution in the beaker containing the frog's skin was replaced at 120 and 150 minutes, there was prompt lightening of the skins. The greater ability of anti-ACTH to inhibit a-MSH, compared to that of anti-MSH, is consistent with the data in Table I , which indicate that anti-ACTH has a higher affinity for a-MSH than does anti-MSH.
In several experiments, 50 jil of either anti-MSH Table I and the degree of antibody excess needed for neutralization of biological activity of a-MSH. Furthermore, the darkening effect of a-MSH is inhibited by anti-ACTH even in the presence of ACTH (Figure 4) , a finding that could not be predicted from the data in Table I .
In Table III (Table II) . In this experiment 100 ,ul of anti-ACTH inhibited by 75%o the response to 0.1 jug of porcine ACTH. Anti-MSH did not inhibit ACTH in this assay.
The several effects of anti-MSH and anti-ACTH are summarized in Table IV .
Discussion
Lack of specificity of the in vitro frog skin bioassay for a-MSH has prevented its general application to clinical problems. The experiments reported here permit the use of antiserum to confer immunologic specificity to the highly sensitive bioassays for a-MSH. Frog skin darkening activity due to a-MSH in human plasma, for example, could be differentiated from that produced by ACTH or f-MSH by inhibition by highly specific anti-MSH.
This study compared the reactivity of immunologic and biologic systems with a-MSH and ACTH. The ability of both antisera to neutralize the biological activity of a-MSH correlated well with their binding of a-MSH as measured by hapten inhibition. This may indicate that these antibodies and the biological receptor react with the same part of the peptide.
The nonspecificity of anti-ACTH is probably related to the inclusion within ACTH of an amino acid sequence common to a-MSH. If one of the sites in RSA-ACTH that induced antibodies in rabbits includes part of this sequence, those antibodies would also react with the similar sequence in a-MSH. On the other hand, the specificity of anti-MSH may be related to the terminal N-acetyl serine present in a-MSH but not in /3-MSH or ACTH. Inclusion of this amino acid in the immunogenic site of a-MSH might result in antibodies specific for a-MSH relative to ACTH and ,8-MSH.
The conjugation of small polypeptides to albumin by reaction with carbodiimides provides a convenient method of synthesis of immunogenic complexes, which induce antibodies specific for the polypeptide moiety. In the case of a-MSH, specific antibodies were rapidly induced by the hormone-RSA conjugate. Unconjugated ACTH, on the other hand, can induce antibodies when injected into rabbits or guinea pigs (6, 7, 12, 13) . Antibodies formed in response to unconjugated ACTH are more specific than those produced in the current study. In fact, Imura, Sparks, Grodsky, and Forsham (13) concluded that their antibodies to ACTH reacted with the part of the ACTH molecule that does not contain the a-MSH sequence. There probably are two or more immunogenic sites in the ACTH molecule. Differences in results may reflect individuality of the antibody-producing animals, as shown by Arquilla and Finn in guinea pigs producing antibodies to insulin (14) . Alternatively, the differences may result from the use of conjugates. Conjugation to albumin may preferentially expose the sites of ACTH resembling MSH to the antibody producing mechanisms.
Anti-ACTH inhibits the adrenocorticotropic function of ACTH but not its skin darkening effect. This observation could be explained if the affinity between the melanocyte and ACTH were greater than the affinity between the peptide and the antibody. Such a proposal would, however, also require the adrenal cortex to have a relatively lower affinity for ACTH than that of the antibody.
Complement fixation in the presence of RSA-ACTH and anti-ACTH was inhibited by both ,8-MSH and ACTH, which indicates that the antibody binds these molecules. Darkening effects of these hormones, however, were not inhibited by the antiserum, which may indicate that the hormone-antibody complex is active at the melanocyte target or that the melanocyte target has very high binding affinity for the hormone compared to the binding by antibody. A large excess of antibody was required for the neutralization of the biological effect compared to the proportions indicated by the immunological data. This supports the idea that melanocytes bind the hormones strongly, compared to their binding by antisera. In in vivo experiments, the antisera were found to prolong the effects of a-MSH in frogs, with variable evidence of neutralization (15) .
The binding of free hormone indicated by the hapten inhibition data permit use of these antisera for immunoassay of a-MSH. The differential abilities of the antisera to neutralize effects of the hormones on frog skin permit their use to add specificity to this sensitive bioassay.
Summary
Adrenocorticotropic hormone (ACTH) and melanocyte stimulating hormone (a-MSH) were conjugated to rabbit serum albumin with carbodiimide reagents, and the induction of antibodies to these complexes in the rabbit is reported.
Complement fixing antibodies to a-MSH were found to be very specific, and they did not crossreact with 8-MSH or ACTH. They neutralized the skin darkening effect of a-MSH on frog skin in vitro. Antiserum to ACTH was less specific, and it reacted with ACTH, the synthetic N-terminal eicosapeptide of ACTH (eicosapeptide "ACTH"), and both a-and f8-MSH. Anti-ACTH neutralized the biological effects of ACTH on rat adrenal gland and adrenal tumor cells and the effect of a-MSH on frog skin. Neither antiserum in the small amounts used neutralized the darkening effect of /8-MSH or ACTH.
